Michel Bourin is a Professor of pharmacology at the University of Nantes, Nantes, France, where he has been the Head of research in the neurobiology of anxiety and depression since 1988. He is also an Adjunct Professor of the Department of Psychiatry at Edmonton University in Alberta, Canada, and a Visiting Professor at the University of Craiova in Rumania. Dr. Bourin has earned degrees in neuropsychopharmacology, clinical pharmacology, and general pharmacology and is a certified psychiatrist. He is Doctor Honoris Causa: University of Tartu (Estonia) and University of Craiova (Romania). Dr. Bourin has been a Member of numerous international medical and psychiatric societies, including the European College of Neuropsychopharmacology (ECNP), the Association Française de Psychiatrie Biologique (AFPB), and the World Health Organisation (WHO) task force on benzodiazepines, where he is currently a WHO expert for drug dependency. He is also a Fellow of the Collegium Internationale Neuro-Psychopharmacologicum. Dr. Bourin is the Chief Editor of Frontiers in Psychopharmacology, an Associate Editor of Neuropsychiatry, and a Field Editor of Fundamental and Clinical Pharmacology. He is also on the boards of numerous journals including Current Psychiatry Reviews, Neuropsychobiology, and World Journal of Psychiatry. Dr. Bourin has a long publishing history, with more than 300 original articles in the field of psychopharmacology and more than 250 educational/review articles or book chapters, in both French and English.
Biography Updated on 1 November 2011